Ectopic pregnancy (US)
Educational tool based on NICE guideline NG126 (2019, update 2023), with a conservative approach. Helps recognize sonographic signs of tubal ectopic pregnancy and reminds of the need for clinical and laboratory correlation.
Interactive checklist
The ⓘ symbol indicates a tooltip with additional information — click (or tap) to view.
References
- National Institute for Health and Care Excellence (NICE). Ectopic pregnancy and miscarriage: diagnosis and initial management. NICE guideline NG126. London: NICE; 2019. Updated 23 Aug 2023. Available at: https://www.nice.org.uk/guidance/ng126
Ultrasound findings of ectopic pregnancy
Read the didactic cards and, in the checklist, select the findings present. The result is updated automatically and does not replace clinical judgment.
Hierarchy of ultrasound findings (NICE)
- Mobile adnexal mass separate from the ovary ("sliding sign") with gestational sac containing yolk sac.
- Mobile adnexal mass separate from the ovary with gestational sac and fetal pole (with or without heartbeat).
- Mobile adnexal mass separate from the ovary with empty gestational sac ("tubal ring"/"bagel sign").
- Complex, heterogeneous, mobile adnexal mass separate from the ovary.
- Empty uterus.
- Pseudosac (fluid in the uterine cavity) — differentiate from early intrauterine sac (double decidual sign).
Free fluid / hemoperitoneum (TAUS or USTV)
- Moderate to large amount of free fluid in the peritoneal cavity or pouch of Douglas may represent hemoperitoneum.
If present, consider intrauterine and adnexal findings, clinical presentation and hCG before concluding. NICE 1.4.20 (2019).
Heterotopic (TAUS or USTV)
- When performing abdominal or transvaginal ultrasonography in early pregnancy, examine the uterus and adnexa to assess for heterotopic pregnancy.
NICE 1.4.21 (2019).
Examiner qualification
- Examinations must be performed or supervised/reviewed by qualified professionals with training and experience in ectopic pregnancy diagnosis.
NICE 1.4.22 (2012, amended 2019).
Before concluding, consider intrauterine and adnexal findings on examination, clinical presentation and serum hCG levels (NICE 2019/2023).